Press releases - 4

Domain Therapeutics presents posters at the American Association for Cancer Research Virtual Annual ...

Domain Therapeutics receives development milestone payment from Merck KGaA, Darmstadt, Germany, fo...

Domain Therapeutics acquires Prestwick Chemical and Neurofit to bolster next stage of growth

Domain Therapeutics is granted European and US patent for biosensors assessing GPCR trafficking

Domain Therapeutics secures €6 million ($6.7M) debt financing

Domain Therapeutics and Pr Michel Bouvier (IRIC Montreal) receive the RSRI award for bioSens-All™ ...

Domain Therapeutics reaches two milestones in multi-target research collaboration with Boehringer In...

Domain Therapeutics invests in Ermium Therapeutics to develop first-in-class CXCR4 candidate for aut...

Domain Therapeutics appoints Xavier Leroy as chief technology officer

Domain Therapeutics strengthens its scientific advisory board with leading GPCR and disease experts